Related Experiment Video
Updated: Feb 26, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
Hiroki Kaneko1, Hiroko Terasaki1
1Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya Japan.
Abstract:
Even with a high surgical success rate for retinal detachment and proliferative vitreoretinopathy (PVR) supported by the robust improvement in vitrectomy surgery and its related devices, certain questions still remain for the pathogenesis and treatment of PVR. One of the important biological events in PVR is epithelial-mesenchymal transition (EMT) of the retinal pigment epithelial (RPE) cells. MicroRNAs are noncoding, small, single-strand RNAs that posttranscriptionally regulate gene expression and have essential roles in homeostasis and pathogenesis in many diseases. Recently, microRNAs also had a critical role in EMT in many tissues and cells. One main purpose of this brief review is to describe the knowledge obtained from microRNA research, especially concerning vitreoretinal diseases. In addition, the potential role of microRNAs in prevention of PVR by regulating EMT in RPE cells is described. Understanding microRNA involvement in PVR could be helpful for developing new biological markers or therapeutic targets and reducing the rate of visual disability due to PVR.
Insights
MicroRNAs play a key role in proliferative vitreoretinopathy (PVR) by regulating epithelial-mesenchymal transition (EMT) in retinal pigment epithelial (RPE) cells. This research explores microRNAs as potential therapeutic targets for preventing PVR and vision loss.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Proliferative vitreoretinopathy (PVR) remains a challenge despite surgical advancements.
- Epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells is a critical pathological event in PVR.
- MicroRNAs are key regulators of gene expression with established roles in cellular processes and disease pathogenesis.
Purpose of the Study:
- To review current knowledge on microRNA involvement in vitreoretinal diseases, particularly PVR.
- To elucidate the role of microRNAs in regulating EMT in RPE cells within the context of PVR.
- To explore the potential of microRNAs as therapeutic targets or biomarkers for PVR.
Main Methods:
- Literature review focusing on microRNA research in PVR and EMT.
- Analysis of existing studies on microRNA function in RPE cells.
- Synthesis of data regarding microRNA-mediated regulation of EMT.
Main Results:
- MicroRNAs are implicated in the EMT process crucial for PVR development.
- Specific microRNAs have been identified to influence RPE cell behavior during PVR.
- MicroRNA dysregulation contributes to the pathogenesis of PVR.
Conclusions:
- MicroRNAs are significant regulators of EMT in RPE cells, contributing to PVR.
- Targeting microRNAs offers a promising strategy for PVR prevention and treatment.
- Further understanding of microRNA pathways could lead to novel biomarkers and therapies for visual impairment due to PVR.
Related Concept Videos
MicroRNAs
MicroRNAs

